Global HMO Infant Formula Market Research Report 2025

Publication ID:

PB503259692

Publication Date:

March 14, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Retailing [2]

Consumer & Retail [3]

Description:

The global market for HMO Infant Formula was valued at US$ 3860 million in the year 2024 and is projected to reach a revised size of US$ 7850 million by 2031, growing at a CAGR of 10.8% during the forecast period.
Human milk oligosaccharides (HMOs) are the third most abundant component in breast milk and one of the most important components in breast milk. It is precisely because of the existence of HMOs that breastfeeding has become the gold standard for infant nutrition. The latest research shows that HMOs can effectively enhance the benefits of breastfeeding, such as strengthening the immune system and promoting healthy brain development. In addition, HMOs can promote intestinal development, improve intestinal resilience, and promote the balance of intestinal microbiota. HMO is particularly important in improving the health and nutritional needs of infants and young children. Since infant formula is mainly made from cow and goat milk, and the content of HMO in cow and goat milk is very low, adding HMO to infant formula is more in line with breast milk nutrition and can better protect the healthy growth of babies.
Global key players of HMO Infant Formula include Nestl茅 (Wyeth Nutrition), Danone (Aptamil), FrieslandCampina (Friso), Abbott, Mead Johnson(Reckitt), etc. The top five players hold a share about 94%. Americas is the world's largest market for HMO Infant Formula and holds a share about 58%, followed by Europe and Asia-Pacific, with share about 28% and 13%, separately. In terms of product type, 2'-FL is the largest segment, accounting for a share about 96%. In terms of application, Online Channel is the largest field with a share about 33 percent.
Report Scope
This report aims to provide a comprehensive presentation of the global market for HMO Infant Formula, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HMO Infant Formula.
The HMO Infant Formula market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global HMO Infant Formula market comprehensively. Regional market sizes, concerning products by Type, by Sales Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HMO Infant Formula manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sales Channel, and by regions.
By Company
Abbott
Mead Johnson锛圧eckitt锛�
Nestl茅锛圵yeth Nutrition锛�
Danone (Aptamil)
FrieslandCampina (Friso)
Biostime
Yili Group (Ausnutria Dairy)
Segment by Type
2'-Fucosyllactose (2'-FL)
Others
Segment by Sales Channel
Online Channel
Specialty Store
Supermarket
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of HMO Infant Formula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of HMO Infant Formula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sales Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 HMO Infant Formula Market Overview
1.1 Product Definition
1.2 HMO Infant Formula by Type
1.2.1 Global HMO Infant Formula Market Value Comparison by Type (2024 VS 2031)
1.2.2 2'-Fucosyllactose (2'-FL)
1.2.3 Others
1.3 HMO Infant Formula by Sales Channel
1.3.1 Global HMO Infant Formula Market Value by Sales Channel (2024 VS 2031)
1.3.2 Online Channel
1.3.3 Specialty Store
1.3.4 Supermarket
1.3.5 Others
1.4 Global HMO Infant Formula Market Size Estimates and Forecasts
1.4.1 Global HMO Infant Formula Revenue 2020-2031
1.4.2 Global HMO Infant Formula Sales 2020-2031
1.4.3 Global HMO Infant Formula Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 HMO Infant Formula Market Competition by Manufacturers
2.1 Global HMO Infant Formula Sales Market Share by Manufacturers (2020-2025)
2.2 Global HMO Infant Formula Revenue Market Share by Manufacturers (2020-2025)
2.3 Global HMO Infant Formula Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of HMO Infant Formula, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of HMO Infant Formula, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of HMO Infant Formula, Product Type & Application
2.7 Global Key Manufacturers of HMO Infant Formula, Date of Enter into This Industry
2.8 Global HMO Infant Formula Market Competitive Situation and Trends
2.8.1 Global HMO Infant Formula Market Concentration Rate
2.8.2 The Global 5 and 10 Largest HMO Infant Formula Players Market Share by Revenue
2.8.3 Global HMO Infant Formula Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global HMO Infant Formula Market Scenario by Region
3.1 Global HMO Infant Formula Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global HMO Infant Formula Sales by Region: 2020-2031
3.2.1 Global HMO Infant Formula Sales by Region: 2020-2025
3.2.2 Global HMO Infant Formula Sales by Region: 2026-2031
3.3 Global HMO Infant Formula Revenue by Region: 2020-2031
3.3.1 Global HMO Infant Formula Revenue by Region: 2020-2025
3.3.2 Global HMO Infant Formula Revenue by Region: 2026-2031
3.4 North America HMO Infant Formula Market Facts & Figures by Country
3.4.1 North America HMO Infant Formula Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America HMO Infant Formula Sales by Country (2020-2031)
3.4.3 North America HMO Infant Formula Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe HMO Infant Formula Market Facts & Figures by Country
3.5.1 Europe HMO Infant Formula Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe HMO Infant Formula Sales by Country (2020-2031)
3.5.3 Europe HMO Infant Formula Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific HMO Infant Formula Market Facts & Figures by Region
3.6.1 Asia Pacific HMO Infant Formula Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific HMO Infant Formula Sales by Region (2020-2031)
3.6.3 Asia Pacific HMO Infant Formula Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America HMO Infant Formula Market Facts & Figures by Country
3.7.1 Latin America HMO Infant Formula Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America HMO Infant Formula Sales by Country (2020-2031)
3.7.3 Latin America HMO Infant Formula Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa HMO Infant Formula Market Facts & Figures by Country
3.8.1 Middle East and Africa HMO Infant Formula Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa HMO Infant Formula Sales by Country (2020-2031)
3.8.3 Middle East and Africa HMO Infant Formula Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global HMO Infant Formula Sales by Type (2020-2031)
4.1.1 Global HMO Infant Formula Sales by Type (2020-2025)
4.1.2 Global HMO Infant Formula Sales by Type (2026-2031)
4.1.3 Global HMO Infant Formula Sales Market Share by Type (2020-2031)
4.2 Global HMO Infant Formula Revenue by Type (2020-2031)
4.2.1 Global HMO Infant Formula Revenue by Type (2020-2025)
4.2.2 Global HMO Infant Formula Revenue by Type (2026-2031)
4.2.3 Global HMO Infant Formula Revenue Market Share by Type (2020-2031)
4.3 Global HMO Infant Formula Price by Type (2020-2031)
5 Segment by Sales Channel
5.1 Global HMO Infant Formula Sales by Sales Channel (2020-2031)
5.1.1 Global HMO Infant Formula Sales by Sales Channel (2020-2025)
5.1.2 Global HMO Infant Formula Sales by Sales Channel (2026-2031)
5.1.3 Global HMO Infant Formula Sales Market Share by Sales Channel (2020-2031)
5.2 Global HMO Infant Formula Revenue by Sales Channel (2020-2031)
5.2.1 Global HMO Infant Formula Revenue by Sales Channel (2020-2025)
5.2.2 Global HMO Infant Formula Revenue by Sales Channel (2026-2031)
5.2.3 Global HMO Infant Formula Revenue Market Share by Sales Channel (2020-2031)
5.3 Global HMO Infant Formula Price by Sales Channel (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott HMO Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott HMO Infant Formula Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Mead Johnson锛圧eckitt锛�
6.2.1 Mead Johnson锛圧eckitt锛� Company Information
6.2.2 Mead Johnson锛圧eckitt锛� Description and Business Overview
6.2.3 Mead Johnson锛圧eckitt锛� HMO Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Mead Johnson锛圧eckitt锛� HMO Infant Formula Product Portfolio
6.2.5 Mead Johnson锛圧eckitt锛� Recent Developments/Updates
6.3 Nestl茅锛圵yeth Nutrition锛�
6.3.1 Nestl茅锛圵yeth Nutrition锛� Company Information
6.3.2 Nestl茅锛圵yeth Nutrition锛� Description and Business Overview
6.3.3 Nestl茅锛圵yeth Nutrition锛� HMO Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nestl茅锛圵yeth Nutrition锛� HMO Infant Formula Product Portfolio
6.3.5 Nestl茅锛圵yeth Nutrition锛� Recent Developments/Updates
6.4 Danone (Aptamil)
6.4.1 Danone (Aptamil) Company Information
6.4.2 Danone (Aptamil) Description and Business Overview
6.4.3 Danone (Aptamil) HMO Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Danone (Aptamil) HMO Infant Formula Product Portfolio
6.4.5 Danone (Aptamil) Recent Developments/Updates
6.5 FrieslandCampina (Friso)
6.5.1 FrieslandCampina (Friso) Company Information
6.5.2 FrieslandCampina (Friso) Description and Business Overview
6.5.3 FrieslandCampina (Friso) HMO Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.5.4 FrieslandCampina (Friso) HMO Infant Formula Product Portfolio
6.5.5 FrieslandCampina (Friso) Recent Developments/Updates
6.6 Biostime
6.6.1 Biostime Company Information
6.6.2 Biostime Description and Business Overview
6.6.3 Biostime HMO Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Biostime HMO Infant Formula Product Portfolio
6.6.5 Biostime Recent Developments/Updates
6.7 Yili Group (Ausnutria Dairy)
6.7.1 Yili Group (Ausnutria Dairy) Company Information
6.7.2 Yili Group (Ausnutria Dairy) Description and Business Overview
6.7.3 Yili Group (Ausnutria Dairy) HMO Infant Formula Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Yili Group (Ausnutria Dairy) HMO Infant Formula Product Portfolio
6.7.5 Yili Group (Ausnutria Dairy) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 HMO Infant Formula Industry Chain Analysis
7.2 HMO Infant Formula Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 HMO Infant Formula Production Mode & Process Analysis
7.4 HMO Infant Formula Sales and Marketing
7.4.1 HMO Infant Formula Sales Channels
7.4.2 HMO Infant Formula Distributors
7.5 HMO Infant Formula Customer Analysis
8 HMO Infant Formula Market Dynamics
8.1 HMO Infant Formula Industry Trends
8.2 HMO Infant Formula Market Drivers
8.3 HMO Infant Formula Market Challenges
8.4 HMO Infant Formula Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Abbott
Mead Johnson锛圧eckitt锛�
Nestl茅锛圵yeth Nutrition锛�
Danone (Aptamil)
FrieslandCampina (Friso)
Biostime
Yili Group (Ausnutria Dairy)

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂